Candriam S.C.A. Scholar Rock Holding Corp Transaction History
Candriam S.C.A.
- $15.6 Billion
- Q1 2025
A detailed history of Candriam S.C.A. transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Candriam S.C.A. holds 496,756 shares of SRRK stock, worth $17.6 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
496,756
Previous 582,354
14.7%
Holding current value
$17.6 Million
Previous $25.2 Million
36.55%
% of portfolio
0.1%
Previous 0.15%
Shares
4 transactions
Others Institutions Holding SRRK
# of Institutions
248Shares Held
89.8MCall Options Held
706KPut Options Held
456K-
Siren, L.L.C. New York, NY9.25MShares$327 Million16.93% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.89MShares$315 Million0.04% of portfolio
-
Black Rock Inc. New York, NY5.66MShares$200 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA5.61MShares$199 Million83.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.85MShares$171 Million0.0% of portfolio
About Scholar Rock Holding Corp
- Ticker SRRK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,640,600
- Market Cap $1.83B
- Description
- Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...